FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W200989902> ?p ?o ?g. }

• W200989902 endingPage "M50" @default.
• W200989902 startingPage "M44" @default.
• W200989902 abstract "Pharmacological therapy for Type 2 (non-insulin-dependent) diabetes mellitus aims at controlling hyperglycaemia to delay or prevent complications associated with the disease. Most patients with Type 2 diabetes present with both stimulated insulin deficiency and insulin resistance. In general, the former can manifest as postprandial hyperglycaemia and the latter as fasting hyperglycaemia, though a definitive association has not been established. Emerging data show a high failure rate of long-term monotherapy and establishes the significance of mealtime glycaemia and the role of postprandial glucose excursions in the development and progression of vascular complications. To overcome such failures of monotherapy and to address the different underlying defects of the pathology of Type 2 diabetes, a combined therapy of oral antidiabetic agents with complementary modes of action should be considered. Currently used oral antidiabetic agents such as sulphonylureas, biguanides (metformin) and the thiazolidinediones (rosiglitazone, pioglitazone) commonly target fasting hyperglycaemia and have limited additive effects on postprandial glycaemia. In contrast, alpha-glucosidase inhibitors can reduce postprandial hyperglycaemia but gastrointestinal side effects restrict their use. The development of new agents to control postprandial glucose excursions could be considered as an additional objective for the management of Type 2 diabetes. To this end new short-acting enhancers of insulin secretion such as repaglinide (benzoic acid derivative) and nateglinide (amino acid derivative) have been developed. The combination of such agents with other complementary modes of action, e.g. an insulin sensitizer, could target better major underlying defects of Type 2 diabetes and thereby provide a better approach for controlling the entire glycaemic risk." @default.
• W200989902 created "2016-06-24" @default.
• W200989902 creator A5010278198 @default.
• W200989902 creator A5026570008 @default.
• W200989902 date "2003-03-01" @default.
• W200989902 modified "2023-09-27" @default.
• W200989902 title "Rationale and options for combination therapy in the treatment of Type 2 diabetes" @default.
• W200989902 cites W157477409 @default.
• W200989902 cites W1964413807 @default.
• W200989902 cites W1975588287 @default.
• W200989902 cites W1977013080 @default.
• W200989902 cites W1981978041 @default.
• W200989902 cites W1993034883 @default.
• W200989902 cites W2000366185 @default.
• W200989902 cites W2007578342 @default.
• W200989902 cites W2015950058 @default.
• W200989902 cites W2017026431 @default.
• W200989902 cites W2017738196 @default.
• W200989902 cites W2023447984 @default.
• W200989902 cites W2027935771 @default.
• W200989902 cites W2028038659 @default.
• W200989902 cites W2032747159 @default.
• W200989902 cites W2032912656 @default.
• W200989902 cites W2036731511 @default.
• W200989902 cites W2042815106 @default.
• W200989902 cites W2043316108 @default.
• W200989902 cites W2053670472 @default.
• W200989902 cites W2059649085 @default.
• W200989902 cites W2069150029 @default.
• W200989902 cites W2076693232 @default.
• W200989902 cites W2078089300 @default.
• W200989902 cites W2080159690 @default.
• W200989902 cites W2084396445 @default.
• W200989902 cites W2084772097 @default.
• W200989902 cites W2106603497 @default.
• W200989902 cites W2125735137 @default.
• W200989902 cites W2131669718 @default.
• W200989902 cites W2154909966 @default.
• W200989902 cites W2159654541 @default.
• W200989902 cites W2170496172 @default.
• W200989902 cites W2170502600 @default.
• W200989902 cites W2186146257 @default.
• W200989902 cites W2188846692 @default.
• W200989902 cites W22189248 @default.
• W200989902 cites W2271771390 @default.
• W200989902 cites W2275139239 @default.
• W200989902 cites W2412099407 @default.
• W200989902 cites W2786617581 @default.
• W200989902 doi "https://doi.org/10.1007/s00125-002-0936-0" @default.
• W200989902 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12652358" @default.
• W200989902 hasPublicationYear "2003" @default.
• W200989902 type Work @default.
• W200989902 sameAs 200989902 @default.
• W200989902 citedByCount "72" @default.
• W200989902 countsByYear W2009899022012 @default.
• W200989902 countsByYear W2009899022013 @default.
• W200989902 countsByYear W2009899022014 @default.
• W200989902 countsByYear W2009899022015 @default.
• W200989902 countsByYear W2009899022016 @default.
• W200989902 countsByYear W2009899022020 @default.
• W200989902 countsByYear W2009899022021 @default.
• W200989902 countsByYear W2009899022022 @default.
• W200989902 crossrefType "journal-article" @default.
• W200989902 hasAuthorship W200989902A5010278198 @default.
• W200989902 hasAuthorship W200989902A5026570008 @default.
• W200989902 hasBestOaLocation W2009899021 @default.
• W200989902 hasConcept C126322002 @default.
• W200989902 hasConcept C134018914 @default.
• W200989902 hasConcept C2777180221 @default.
• W200989902 hasConcept C2778199505 @default.
• W200989902 hasConcept C2778384471 @default.
• W200989902 hasConcept C2779306644 @default.
• W200989902 hasConcept C2779463123 @default.
• W200989902 hasConcept C2780152017 @default.
• W200989902 hasConcept C2780323712 @default.
• W200989902 hasConcept C2781281211 @default.
• W200989902 hasConcept C2910068830 @default.
• W200989902 hasConcept C555293320 @default.
• W200989902 hasConcept C71924100 @default.
• W200989902 hasConceptScore W200989902C126322002 @default.
• W200989902 hasConceptScore W200989902C134018914 @default.
• W200989902 hasConceptScore W200989902C2777180221 @default.
• W200989902 hasConceptScore W200989902C2778199505 @default.
• W200989902 hasConceptScore W200989902C2778384471 @default.
• W200989902 hasConceptScore W200989902C2779306644 @default.
• W200989902 hasConceptScore W200989902C2779463123 @default.
• W200989902 hasConceptScore W200989902C2780152017 @default.
• W200989902 hasConceptScore W200989902C2780323712 @default.
• W200989902 hasConceptScore W200989902C2781281211 @default.
• W200989902 hasConceptScore W200989902C2910068830 @default.
• W200989902 hasConceptScore W200989902C555293320 @default.
• W200989902 hasConceptScore W200989902C71924100 @default.
• W200989902 hasIssue "S1" @default.
• W200989902 hasLocation W2009899021 @default.
• W200989902 hasLocation W2009899022 @default.
• W200989902 hasOpenAccess W200989902 @default.
• W200989902 hasPrimaryLocation W2009899021 @default.
• W200989902 hasRelatedWork W2000362216 @default.

• next